Pascal Finetti

36PUBLICATIONS
135CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMechanobiologyPacific Peoples genomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Feb 05, 2026
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Mariella Spalato Ceruso, Jean-Philippe Guégan, Aurelien Bourdon

|Feb 02, 2026
Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value.

Maelle Picard, Arnaud Guille, Pascal Finetti

|Dec 12, 2025
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage.

Georgios Efthymiou, Eugénie Lohmann, Claudio Montenegro

|Oct 29, 2025
Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Chaïma Cherif, Dang Tan Nguyen, Clément Paris

|Jul 02, 2025
Gene expression-based rationale for investigating CDK4/6 inhibitors in primitive myelofibrosis.

Anne Murati, Pascal Finetti, Estelle Duprez

|Mar 04, 2025
An antisense oligonucleotide targeting the heat-shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis.

Pierre-Marie Boutanquoi, Lenny Pommerolle, Lucile Dondaine

Pageof 6

Frequent Collaborators

20 joint publications

François Bertucci

9 joint publications

Emilie Mamessier

7 joint publications

Daniel Birnbaum

6 joint publications

Max Chaffanet